IOLs in the ambulatory surgical center setting
This article was originally published in The Gray Sheet
Executive Summary
Requests for CMS to review the "appropriateness" of the $50 new technology intraocular lens payment will be accepted until March 29. The agency is required by statute to review the amount every five years. Advanced Medical Optics contends that the ASC system should be reformed to evaluate new technology every year (1"The Gray Sheet" Dec. 8, 2003, p. 11)...
You may also be interested in...
Cataract Procedures Could See Higher ASC Reimbursement Under Rx Bill
GAO will conduct a study by Jan. 1, 2005 examining the feasibility of using hospital OPPS claims data as a basis to set payment rates for ambulatory surgical centers, under a provision in the Medicare bill
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.